{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:29:25Z","timestamp":1774121365594,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T00:00:00Z","timestamp":1210377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s10096-008-0519-1","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T10:24:02Z","timestamp":1210328642000},"page":"907-913","source":"Crossref","is-referenced-by-count":81,"title":["Performance of two commercial blood IFN-\u03b3 release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-\u03b1 treatment"],"prefix":"10.1007","volume":"27","author":[{"given":"M.","family":"Bocchino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Matarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bellofiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Balato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Signoriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Galati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ponticiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sanduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,10]]},"reference":[{"key":"519_CR1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1469-0691.2006.01546.x","volume":"12","author":"MP Moiton","year":"2006","unstructured":"Moiton MP, Richez C, Dumoulin C, Mehsen N, Dehais J, Schaeverbeke T (2006) Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections. Clin Microbiol Infect 12:1151\u20131153","journal-title":"Clin Microbiol Infect"},{"key":"519_CR2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ncprheum0336","volume":"2","author":"KL Winthrop","year":"2006","unstructured":"Winthrop KL (2006) Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2:602\u2013610","journal-title":"Nat Clin Pract Rheumatol"},{"key":"519_CR3","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","volume":"8","author":"H Hamdi","year":"2006","unstructured":"Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D: RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group (2006) Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Res Ther 8:R114","journal-title":"Arthritis Res Ther"},{"key":"519_CR4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/505430","volume":"194","author":"OY Saliu","year":"2006","unstructured":"Saliu OY, Sofer C, Stein DS, Schwander SK, Wallis RS (2006) Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. J Infect Dis 194:486\u2013492","journal-title":"J Infect Dis"},{"key":"519_CR5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"Joint Tuberculosis Committee of the British Thoracic Society","year":"2005","unstructured":"Joint Tuberculosis Committee of the British Thoracic Society (2005) BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60:800\u2013805","journal-title":"Thorax"},{"key":"519_CR6","first-page":"413","volume":"24","author":"G Valesini","year":"2006","unstructured":"Valesini G, Montecucco C, Cutolo M (2006) Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy. Clin Exp Rheumatol 24:413\u2013423","journal-title":"Clin Exp Rheumatol"},{"key":"519_CR7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/thx.2005.042457","volume":"60","author":"G Provenzano","year":"2005","unstructured":"Provenzano G, Ferrante MC, Simon G (2005) TB screening and anti-TNF alpha treatment. Thorax 60:613","journal-title":"Thorax"},{"key":"519_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","volume":"159","author":"D Menzies","year":"1999","unstructured":"Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159:15\u201321","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR9","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","volume":"17","author":"RE Huebner","year":"1993","unstructured":"Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17:968\u2013975","journal-title":"Clin Infect Dis"},{"key":"519_CR10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/ajrccm.163.4.ed0201c","volume":"163","author":"PF Barnes","year":"2001","unstructured":"Barnes PF (2001) Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med 163:807\u2013808","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","volume":"170","author":"T Mori","year":"2004","unstructured":"Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170:59\u201364","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","volume":"163","author":"A Lalvani","year":"2001","unstructured":"Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, Pasvol G, Hill AV (2001) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163:824\u2013828","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/14787210.3.6.981","volume":"3","author":"JS Rothel","year":"2005","unstructured":"Rothel JS, Andersen P (2005) Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 3:981\u2013993","journal-title":"Expert Rev Anti Infect Ther"},{"key":"519_CR14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4:761\u2013476","journal-title":"Lancet Infect Dis"},{"key":"519_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10096-005-1377-8","volume":"24","author":"T Meier","year":"2005","unstructured":"Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T (2005) Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24:529\u2013536","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"519_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CDLI.12.4.491-496.2005","volume":"12","author":"P Ravn","year":"2005","unstructured":"Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD, Nielsen LN, Kok-Jensen A, Andersen P, Weldingh K (2005) Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 12:491\u2013496","journal-title":"Clin Diagn Lab Immunol"},{"key":"519_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","volume":"28","author":"JY Lee","year":"2006","unstructured":"Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS (2006) Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 28:24\u201330","journal-title":"Eur Respir J"},{"key":"519_CR18","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(00)05115-1","volume":"357","author":"A Lalvani","year":"2001","unstructured":"Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Deeks JJ, Reece WH, Latif M, Pasvol G, Hill AV (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357:2017\u20132021","journal-title":"Lancet"},{"key":"519_CR19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","volume":"361","author":"K Ewer","year":"2003","unstructured":"Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Anderson P, Monk P, Lalvani A (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361:1168\u20131173","journal-title":"Lancet"},{"key":"519_CR20","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200211220-00008","volume":"16","author":"AL Chapman","year":"2002","unstructured":"Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, Reece WH, Mwinga A, Godfrey-Faussett P, Lalvani A (2002) Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16:2285\u20132293","journal-title":"AIDS"},{"key":"519_CR21","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(04)17592-2","volume":"364","author":"S Liebeschuetz","year":"2004","unstructured":"Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A (2004) Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364:2196\u20132203","journal-title":"Lancet"},{"key":"519_CR22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/QAD.0b013e328012164b","volume":"21","author":"M Hoffmann","year":"2007","unstructured":"Hoffmann M, Reichmuth M, Fantelli K, Schoch OD, Fierz W, Furrer H, Vernazza P (2007) Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS 21:390\u2013392","journal-title":"AIDS"},{"key":"519_CR23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2249.2007.03477.x","volume":"150","author":"SA Clark","year":"2007","unstructured":"Clark SA, Martin SL, Pozniak A, Steel A, Ward B, Dunning J, Henderson DC, Nelson M, Gazzard B, Kelleher P (2007) Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 150:238\u2013244","journal-title":"Clin Exp Immunol"},{"key":"519_CR24","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161:1376\u20131395","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR25","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, G\u00f3mez-Reino JJ, Rodr\u00edguez-Valverde V, Montero D, Pascual-G\u00f3mez E, Mola EM, Carre\u00f1o L, Figueroa M; BIOBADASER Group (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766\u20131772","journal-title":"Arthritis Rheum"},{"key":"519_CR26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","volume":"50","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K, Anderson J, Urbansky K (2004) Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 50:372\u2013379","journal-title":"Arthritis Rheum"},{"key":"519_CR27","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","volume":"52","author":"J Askling","year":"2005","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, C\u00f6ster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantap\u00e4\u00e4-Dahlqvist S, Saxne T, Romanus V, Klareskog L, Feltelius N (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52:1986\u20131992","journal-title":"Arthritis Rheum"},{"key":"519_CR28","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","author":"YA Kang","year":"2005","unstructured":"Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293:2756\u20132761","journal-title":"JAMA"},{"key":"519_CR29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","volume":"172","author":"G Ferrara","year":"2005","unstructured":"Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D\u2019Amico R, Marchegiano P, Rumpianesi P, Fabbri LM, Richeldi L (2005) Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 172:631\u2013635","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR30","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","volume":"367","author":"G Ferrara","year":"2006","unstructured":"Ferrara G, Losi M, D\u2019Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367:1328\u20131334","journal-title":"Lancet"},{"key":"519_CR31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/thx.2005.048033","volume":"61","author":"TG Connell","year":"2006","unstructured":"Connell TG, Curtis N, Ranganathan SC, Buttery JP (2006) Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 61:616\u2013620","journal-title":"Thorax"},{"key":"519_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.06.00110205","volume":"28","author":"F Piana","year":"2006","unstructured":"Piana F, Codecasa LR, Cavallerio P, Ferrarese M, Migliori GB, Barbarano L, Morra E, Cirillo DM (2006) Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 28:31\u201334","journal-title":"Eur Respir J"},{"key":"519_CR33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/rccm.200608-1099OC","volume":"175","author":"SM Arend","year":"2007","unstructured":"Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW (2007) Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 175:618\u2013627","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"D Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146:340\u2013354","journal-title":"Ann Intern Med"},{"key":"519_CR35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","volume":"175","author":"AF Luetkemeyer","year":"2007","unstructured":"Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV (2007) Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 175:737\u2013742","journal-title":"Am J Respir Crit Care Med"},{"key":"519_CR36","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1097\/01.aids.0000191923.08938.5b","volume":"19","author":"K Dheda","year":"2005","unstructured":"Dheda K, Lalvani A, Miller RF, Scott G, Booth H, Johnson MA, Zumla A, Rook GA (2005) Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 19:2038\u20132041","journal-title":"AIDS"},{"key":"519_CR37","first-page":"49","volume":"54","author":"GH Mazurek","year":"2005","unstructured":"Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC) (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54:49\u201355","journal-title":"MMWR Recomm Rep"},{"key":"519_CR38","volume-title":"Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control","author":"National Collaborating Centre for Chronic Conditions","year":"2006","unstructured":"National Collaborating Centre for Chronic Conditions (2006) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians, London, UK"},{"key":"519_CR39","unstructured":"Documento sull\u2019utilizzo dei nuovi test immunologici per la diagnosi di infezione tubercolare latente. Elaborato dei Gruppi di Studio Infezioni e Tubercolosi dell\u2019Associazione Italiana Pneumologi Ospedalieri (AIPO) e della Societ\u00e0 Italiana di Medicina Respiratoria (SIMeR). 15 giugno 2006, http:\/\/www.simernet.it"},{"key":"519_CR40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2005.040055","volume":"65","author":"BE Joven","year":"2006","unstructured":"Joven BE, Almod\u00f3var R, Galindo M, Mateo I, Pablos JL (2006) Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response? Ann Rheum Dis 65:699","journal-title":"Ann Rheum Dis"},{"key":"519_CR41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/thx.2005.049759","volume":"61","author":"L Richeldi","year":"2006","unstructured":"Richeldi L, Ewer K, Losi M, Roversi P, Fabbri LM, Lalvani A (2006) Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 61:180","journal-title":"Thorax"},{"key":"519_CR42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1164\/ajrccm.175.2.200","volume":"175","author":"L Richeldi","year":"2007","unstructured":"Richeldi L (2007) Should individuals who are tuberculin skin test negative and positive to RD1-IFN-gamma assay receive preventive therapy? Am J Respir Crit Care Med 175:200","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-008-0519-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-008-0519-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-008-0519-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T12:02:59Z","timestamp":1588680179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-008-0519-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1007\/s10096-008-0519-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,10]]}}}